Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform

Supporting Rakuten Medical’s efforts to accelerate its global Phase 3 study with the goal of achieving approval of ASP-1929 in US as soon as possible Also supporting development of additional pipeline using the Alluminox™ platform, including ASP-1929 photoimmunotherapy in combination with…